Innate Immunity to Nanomaterials View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2018-05-26

AUTHORS

Dong Soo Lee , Young Kee Shin

ABSTRACT

Nanomaterials, if injected to the body systemically, will meet circulating innate immune mediators first and then tissue-resident macrophages. In this chapter, the recent development of the understanding of the innate immunity, mostly the origin and contribution of tissue-resident macrophages was explained. Interestingly, recently tissue-resident macrophages, major player of innate immunity are not derived from circulating monocyte, especially in liver. Tissue resident-macrophages, which are in non-activated state and will act as first-hand gatekeeper to respond to the injected nanomaterials. This innate immunity has the capability of memory and trainability, which means on the second injection, the degree of response will be higher. This trained innate immunity is now known to be meditated by epigenetic modification. Accelerated blood clearance is the minor and benign aftereffect of the action of innate immune response and the activation of pentraxin and complement system or provocation of humoral or cellular adaptive immune response is the consequential aftereffect of immune responses to the nanomaterials. The differentiation between innate and adaptive immunity lies in the presence or absence of involvement of major histocompatibility (MHC) molecules and of V(D)J recombination in effector cells and molecules (Immunoglobulins or T cell receptors). As is expected, circulation physiology predates immune response and thus one can refer to the anatomy of liver and spleen detailed in the chapter to predict the fate and final disposal of injected nanomaterials. More... »

PAGES

389-407

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_21

DOI

http://dx.doi.org/10.1007/978-3-319-67720-0_21

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104232190


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea", 
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "id": "sg:person.015617314175.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy, Seoul National University, 08826, Seoul, Republic of Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea", 
            "The Center for Anti-Cancer Companion Diagnostics, Bio-MAX/N-Bio, Seoul National University, 08826, Seoul, Republic of Korea", 
            "Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy, Seoul National University, 08826, Seoul, Republic of Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shin", 
        "givenName": "Young Kee", 
        "id": "sg:person.01315644246.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315644246.90"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2018-05-26", 
    "datePublishedReg": "2018-05-26", 
    "description": "Nanomaterials, if injected to the body systemically, will meet circulating innate immune mediators first and then tissue-resident macrophages. In this chapter, the recent development of the understanding of the innate immunity, mostly the origin and contribution of tissue-resident macrophages was explained. Interestingly, recently tissue-resident macrophages, major player of innate immunity are not derived from circulating monocyte, especially in liver. Tissue resident-macrophages, which are in non-activated state and will act as first-hand gatekeeper to respond to the injected nanomaterials. This innate immunity has the capability of memory and trainability, which means on the second injection, the degree of response will be higher. This trained innate immunity is now known to be meditated by epigenetic modification. Accelerated blood clearance is the minor and benign aftereffect of the action of innate immune response and the activation of pentraxin and complement system or provocation of humoral or cellular adaptive immune response is the consequential aftereffect of immune responses to the nanomaterials. The differentiation between innate and adaptive immunity lies in the presence or absence of involvement of major histocompatibility (MHC) molecules and of V(D)J recombination in effector cells and molecules (Immunoglobulins or T cell receptors). As is expected, circulation physiology predates immune response and thus one can refer to the anatomy of liver and spleen detailed in the chapter to predict the fate and final disposal of injected nanomaterials.", 
    "editor": [
      {
        "familyName": "Lee", 
        "givenName": "Dong Soo", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-319-67720-0_21", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-319-67719-4", 
        "978-3-319-67720-0"
      ], 
      "name": "Radionanomedicine", 
      "type": "Book"
    }, 
    "keywords": [
      "tissue-resident macrophages", 
      "immune response", 
      "innate immunity", 
      "cellular adaptive immune response", 
      "innate immune mediators", 
      "adaptive immune responses", 
      "innate immune response", 
      "major histocompatibility molecules", 
      "absence of involvement", 
      "accelerated blood clearance", 
      "immune mediators", 
      "effector cells", 
      "adaptive immunity", 
      "second injection", 
      "degree of response", 
      "blood clearance", 
      "non-activated state", 
      "complement system", 
      "immunity", 
      "histocompatibility molecules", 
      "macrophages", 
      "liver", 
      "response", 
      "epigenetic modifications", 
      "spleen", 
      "pentraxins", 
      "clearance", 
      "injected nanomaterials", 
      "injection", 
      "mediators", 
      "tissue", 
      "anatomy", 
      "major players", 
      "activation", 
      "involvement", 
      "provocation", 
      "aftereffects", 
      "capability of memory", 
      "cells", 
      "differentiation", 
      "absence", 
      "action", 
      "body", 
      "presence", 
      "gatekeepers", 
      "trainability", 
      "molecules", 
      "development", 
      "degree", 
      "recent developments", 
      "players", 
      "origin", 
      "memory", 
      "understanding", 
      "fate", 
      "modification", 
      "chapter", 
      "state", 
      "system", 
      "contribution", 
      "disposal", 
      "recombination", 
      "capability", 
      "nanomaterials", 
      "final disposal"
    ], 
    "name": "Innate Immunity to Nanomaterials", 
    "pagination": "389-407", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104232190"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-319-67720-0_21"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-319-67720-0_21", 
      "https://app.dimensions.ai/details/publication/pub.1104232190"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-12-01T06:49", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/chapter/chapter_26.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-319-67720-0_21"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_21'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_21'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_21'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-67720-0_21'


 

This table displays all metadata directly associated to this object as RDF triples.

135 TRIPLES      22 PREDICATES      88 URIs      81 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-319-67720-0_21 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author Nf0474e13ae0943668e2307dab7fead6f
4 schema:datePublished 2018-05-26
5 schema:datePublishedReg 2018-05-26
6 schema:description Nanomaterials, if injected to the body systemically, will meet circulating innate immune mediators first and then tissue-resident macrophages. In this chapter, the recent development of the understanding of the innate immunity, mostly the origin and contribution of tissue-resident macrophages was explained. Interestingly, recently tissue-resident macrophages, major player of innate immunity are not derived from circulating monocyte, especially in liver. Tissue resident-macrophages, which are in non-activated state and will act as first-hand gatekeeper to respond to the injected nanomaterials. This innate immunity has the capability of memory and trainability, which means on the second injection, the degree of response will be higher. This trained innate immunity is now known to be meditated by epigenetic modification. Accelerated blood clearance is the minor and benign aftereffect of the action of innate immune response and the activation of pentraxin and complement system or provocation of humoral or cellular adaptive immune response is the consequential aftereffect of immune responses to the nanomaterials. The differentiation between innate and adaptive immunity lies in the presence or absence of involvement of major histocompatibility (MHC) molecules and of V(D)J recombination in effector cells and molecules (Immunoglobulins or T cell receptors). As is expected, circulation physiology predates immune response and thus one can refer to the anatomy of liver and spleen detailed in the chapter to predict the fate and final disposal of injected nanomaterials.
7 schema:editor N47918c85640f40418356f4139118d4b0
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N52876eacf2724130b90eea4e6a17e129
11 schema:keywords absence
12 absence of involvement
13 accelerated blood clearance
14 action
15 activation
16 adaptive immune responses
17 adaptive immunity
18 aftereffects
19 anatomy
20 blood clearance
21 body
22 capability
23 capability of memory
24 cells
25 cellular adaptive immune response
26 chapter
27 clearance
28 complement system
29 contribution
30 degree
31 degree of response
32 development
33 differentiation
34 disposal
35 effector cells
36 epigenetic modifications
37 fate
38 final disposal
39 gatekeepers
40 histocompatibility molecules
41 immune mediators
42 immune response
43 immunity
44 injected nanomaterials
45 injection
46 innate immune mediators
47 innate immune response
48 innate immunity
49 involvement
50 liver
51 macrophages
52 major histocompatibility molecules
53 major players
54 mediators
55 memory
56 modification
57 molecules
58 nanomaterials
59 non-activated state
60 origin
61 pentraxins
62 players
63 presence
64 provocation
65 recent developments
66 recombination
67 response
68 second injection
69 spleen
70 state
71 system
72 tissue
73 tissue-resident macrophages
74 trainability
75 understanding
76 schema:name Innate Immunity to Nanomaterials
77 schema:pagination 389-407
78 schema:productId N2bfa9d3c934c41d89a5e076c19e3179f
79 Ne69901d69c904e23b43305ac413012d0
80 schema:publisher N3d825d761b734154a1a4852f8bdbe289
81 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104232190
82 https://doi.org/10.1007/978-3-319-67720-0_21
83 schema:sdDatePublished 2022-12-01T06:49
84 schema:sdLicense https://scigraph.springernature.com/explorer/license/
85 schema:sdPublisher N319517b3038d47248341922b0716fcb3
86 schema:url https://doi.org/10.1007/978-3-319-67720-0_21
87 sgo:license sg:explorer/license/
88 sgo:sdDataset chapters
89 rdf:type schema:Chapter
90 N226a8d2826904096879527c00684311f rdf:first sg:person.01315644246.90
91 rdf:rest rdf:nil
92 N2bfa9d3c934c41d89a5e076c19e3179f schema:name dimensions_id
93 schema:value pub.1104232190
94 rdf:type schema:PropertyValue
95 N319517b3038d47248341922b0716fcb3 schema:name Springer Nature - SN SciGraph project
96 rdf:type schema:Organization
97 N3d825d761b734154a1a4852f8bdbe289 schema:name Springer Nature
98 rdf:type schema:Organisation
99 N47918c85640f40418356f4139118d4b0 rdf:first Na6397092db8b425796e58996992a9ef2
100 rdf:rest rdf:nil
101 N52876eacf2724130b90eea4e6a17e129 schema:isbn 978-3-319-67719-4
102 978-3-319-67720-0
103 schema:name Radionanomedicine
104 rdf:type schema:Book
105 Na6397092db8b425796e58996992a9ef2 schema:familyName Lee
106 schema:givenName Dong Soo
107 rdf:type schema:Person
108 Ne69901d69c904e23b43305ac413012d0 schema:name doi
109 schema:value 10.1007/978-3-319-67720-0_21
110 rdf:type schema:PropertyValue
111 Nf0474e13ae0943668e2307dab7fead6f rdf:first sg:person.015617314175.88
112 rdf:rest N226a8d2826904096879527c00684311f
113 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
114 schema:name Medical and Health Sciences
115 rdf:type schema:DefinedTerm
116 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
117 schema:name Immunology
118 rdf:type schema:DefinedTerm
119 sg:person.01315644246.90 schema:affiliation grid-institutes:grid.31501.36
120 schema:familyName Shin
121 schema:givenName Young Kee
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315644246.90
123 rdf:type schema:Person
124 sg:person.015617314175.88 schema:affiliation grid-institutes:grid.31501.36
125 schema:familyName Lee
126 schema:givenName Dong Soo
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015617314175.88
128 rdf:type schema:Person
129 grid-institutes:grid.31501.36 schema:alternateName Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea
130 Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy, Seoul National University, 08826, Seoul, Republic of Korea
131 schema:name Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, 03080, Seoul, Republic of Korea
132 Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea
133 Laboratory of Molecular Pathology and Cancer Genomics, College of Pharmacy, Seoul National University, 08826, Seoul, Republic of Korea
134 The Center for Anti-Cancer Companion Diagnostics, Bio-MAX/N-Bio, Seoul National University, 08826, Seoul, Republic of Korea
135 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...